ALPMY and 4503:JP Related Headlines

Go Back

May 28, 2026 10:37AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,600 at Macquarie

May 4, 2026 12:59AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,400 at Citi

May 1, 2026 07:15AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,400 at Citi

Apr 15, 2026 08:15AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,450 at Goldman Sachs

Mar 23, 2026 06:29AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Raised to JPY2,500 at JPMorgan

Mar 23, 2026 04:29AM Jefferies Upgrades Astellas Pharma Inc (4503:JP) (ALPMY) to Buy

Mar 17, 2026 06:41AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Raised to JPY2,800 at Macquarie

Mar 12, 2026 08:24AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Raised to JPY2,200 at Bernstein SocGen Group

Feb 19, 2026 05:08AM Nomura/Instinet Downgrades Astellas Pharma Inc (4503:JP) (ALPMY) to Neutral

Jan 26, 2026 05:30AM UBS Starts Astellas Pharma Inc (4503:JP) (ALPMY) at Neutral

Dec 17, 2025 07:08AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Raised to JPY2,250 at Goldman Sachs

Sep 4, 2025 04:29AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Raised to JPY1,900 at JPMorgan

Sep 2, 2025 06:00AM Bernstein SocGen Group Downgrades Astellas Pharma Inc (4503:JP) (ALPMY) to Market Perform

ALPMY and 4503:JP Related Press Releases

Go Back

ALPMY and 4503:JP Related SEC Filings

Go Back